Detalhe da pesquisa
1.
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.
N Engl J Med
; 389(4): 335-347, 2023 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37272512
2.
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.
Blood
; 139(26): 3722-3731, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439295
3.
Brentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas.
Haematologica
; 106(6): 1705-1713, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414850
4.
Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies.
Am J Hematol
; 96(4): 455-461, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529419
5.
Early positron emission tomography/computed tomography as a predictor of response after CTL019 chimeric antigen receptor -T-cell therapy in B-cell non-Hodgkin lymphomas.
Cytotherapy
; 20(12): 1415-1418, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30385043
6.
Outcomes of patients with relapsed/refractory Hodgkin lymphoma progressing after autologous stem cell transplant in the current era of novel therapeutics: A retrospective analysis.
Am J Hematol
; 92(9): 879-884, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28512788
7.
Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era.
Am J Hematol
; 88(10): 890-4, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23813874
8.
A Potential Role Exists for Nutritional Interventions in the Chronic Phase of Mild Traumatic Brain Injury, Concussion and Sports-Related Concussion: A Systematic Review.
Nutrients
; 15(17)2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686758
9.
Second Autologous Stem Cell Transplant as Salvage in Multiple Myeloma - The Oregon Health and Science University Experience.
Clin Lymphoma Myeloma Leuk
; 22(2): 105-112, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34686447
10.
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis.
Transplant Cell Ther
; 27(1): 46-52, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33002640
11.
Preparing Trainees to Deliver High-Value and Cost-Conscious Care in Hematology.
Curr Hematol Malig Rep
; 15(4): 248-253, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632656
12.
Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment.
Curr Treat Options Neurol
; 21(8): 40, 2019 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31327064
13.
Correction to: Chimeric Antigen Receptor T Cell-Related Neurotoxicity: Mechanisms, Clinical Presentation, and Approach to Treatment.
Curr Treat Options Neurol
; 21(9): 43, 2019 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396717
14.
Postural sway, falls, and self-reported neuropathy in aging female cancer survivors.
Gait Posture
; 69: 136-142, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30716669
15.
Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.
Clin Chest Med
; 38(4): 771-783, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29128025
16.
Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS.
Int J Hematol Oncol
; 6(4): 113-121, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30302232
17.
The Promise of Chimeric Antigen Receptor Engineered T Cells in the Treatment of Hematologic Malignancies.
Cancer J
; 22(1): 27-33, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26841014
18.
The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.
Cancer Med
; 4(1): 7-15, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25205600
19.
A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset.
J Rheumatol
; 39(6): 1241-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22467932